- Corporate Officers - D
- Davis Stephen
Insider Trading History of Davis Stephen
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Davis Stephen since 2010.
This trader's CIK number is 1131146.
At the time of last reporting, Davis Stephen was the CEO of Acadia Pharmaceuticals Inc. (stock ticker symbol ACAD).
Also see all insider trading activities at Acadia Pharmaceuticals Inc.
Note that in the past
DAVIS STEPHEN also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Bellicum Pharmaceuticals, Inc (BLCM) by Davis Stephen
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2023 | BLCM | 0 | $0 | 0 | $0 | 74,739 | $0 |
2022 | BLCM | 0 | $0 | 0 | $0 | 62,115 | $0 |
Yearly summary of insider trading at Heron Therapeutics, Inc. /de/ (HRTX) by Davis Stephen
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2014 | HRTX | 0 | $0 | 0 | $0 | 120,313 | $866,253 |
Yearly summary of insider trading at Intrabiotics Pharmaceuticals Inc /de (RDEA) by Davis Stephen
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2012 | RDEA | 0 | $0 | 700 | $11,137 | 0 | $0 |
2011 | RDEA | 0 | $0 | 5,167 | $130,099 | 0 | $0 |
2010 | RDEA | 0 | $0 | 351 | $7,692 | 0 | $0 |
Yearly summary of insider trading at Acadia Pharmaceuticals Inc (ACAD) by Davis Stephen
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2024 | ACAD | 0 | $0 | 96,771 | $1,720,018 | 94,864 | $0 |
2023 | ACAD | 0 | $0 | 247,308 | $6,390,014 | 257,430 | $2,077,000 |
2022 | ACAD | 0 | $0 | 12,005 | $229,721 | 31,090 | $0 |
2021 | ACAD | 0 | $0 | 28,492 | $1,115,419 | 31,090 | $0 |
2020 | ACAD | 0 | $0 | 209,730 | $9,707,872 | 221,562 | $3,929,999 |
2019 | ACAD | 0 | $0 | 302,983 | $13,952,573 | 305,937 | $5,894,999 |
Insider trading activities at 4 companies by Davis Stephen:
1. Bellicum Pharmaceuticals, Inc (BLCM)
2. Heron Therapeutics, Inc. /de/ (HRTX)
3. Intrabiotics Pharmaceuticals Inc /de (RDEA)
4. Acadia Pharmaceuticals Inc (ACAD)
Table 1. Insider trading of Bellicum Pharmaceuticals, Inc (BLCM) by Davis Stephen
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2023-01-03 | BLCM | Option Ex | 74,739 | .00 | 0 |
2022-09-01 | BLCM | Option Ex | 43,400 | .00 | 0 |
2022-01-04 | BLCM | Option Ex | 18,715 | .00 | 0 |
Table 2. Insider trading of Heron Therapeutics, Inc. /de/ (HRTX) by Davis Stephen
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2014-09-26 | HRTX | Option Ex | 120,313 | 7.20 | 866,253 |
Table 3. Insider trading of Intrabiotics Pharmaceuticals Inc /de (RDEA) by Davis Stephen
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2012-01-06 | RDEA | Sale | 700 | 15.91 | 11,137 |
2011-11-15 | RDEA | Sale | 432 | 18.86 | 8,145 |
2011-10-06 | RDEA | Sale | 700 | 15.43 | 10,803 |
2011-07-06 | RDEA | Sale | 700 | 25.65 | 17,957 |
2011-05-16 | RDEA | Sale | 335 | 25.67 | 8,600 |
2011-04-08 | RDEA | Sale | 3,000 | 28.20 | 84,594 |
2010-11-22 | RDEA | Sale | 351 | 21.92 | 7,692 |
Table 4. Insider trading of Acadia Pharmaceuticals Inc (ACAD) by Davis Stephen
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2024-08-19 | ACAD | Sale | 31,747 | 15.28 | 485,094 |
2024-05-02 | ACAD | Sale | 11,427 | 16.94 | 193,573 |
2024-05-01 | ACAD | Option Ex | 22,391 | .00 | 0 |
2024-04-08 | ACAD | Sale | 26,574 | 17.87 | 474,877 |
2024-04-05 | ACAD | Option Ex | 51,999 | .00 | 0 |
2024-03-27 | ACAD | Sale | 17,714 | 17.90 | 317,080 |
2024-02-26 | ACAD | Sale | 5,577 | 24.67 | 137,584 |
2024-02-23 | ACAD | Option Ex | 10,946 | .00 | 0 |
2024-01-08 | ACAD | Sale | 3,732 | 29.96 | 111,810 |
2024-01-06 | ACAD | Option Ex | 9,528 | .00 | 0 |
2023-10-05 | ACAD | Option Ex | 103,999 | .00 | 0 |
2023-10-06 | ACAD | Sale | 51,563 | 21.96 | 1,132,323 |
2023-07-14 | ACAD | Option Ex | 100,000 | 20.77 | 2,077,000 |
2023-07-14 | ACAD | Sale | 100,000 | 30.04 | 3,004,400 |
2023-07-11 | ACAD | Sale | 16,498 | 25.00 | 412,450 |
2023-07-12 | ACAD | Sale | 55,104 | 25.05 | 1,380,465 |
2023-05-01 | ACAD | Sale | 7,806 | 21.18 | 165,331 |
2023-04-29 | ACAD | Option Ex | 15,625 | .00 | 0 |
2023-04-05 | ACAD | Option Ex | 17,333 | .00 | 0 |
2023-04-06 | ACAD | Sale | 8,582 | 18.16 | 155,849 |
2023-02-23 | ACAD | Option Ex | 10,945 | .00 | 0 |
2023-02-24 | ACAD | Sale | 3,851 | 18.78 | 72,321 |
2023-01-09 | ACAD | Sale | 3,904 | 17.13 | 66,875 |
2023-01-06 | ACAD | Option Ex | 9,528 | .00 | 0 |
2022-10-15 | ACAD | Option Ex | 5,938 | .00 | 0 |
2022-10-15 | ACAD | Sale | 2,804 | 15.81 | 44,331 |
2022-04-29 | ACAD | Option Ex | 15,625 | .00 | 0 |
2022-05-02 | ACAD | Sale | 5,483 | 18.18 | 99,691 |
2022-01-06 | ACAD | Option Ex | 9,527 | .00 | 0 |
2022-01-06 | ACAD | Sale | 3,718 | 23.05 | 85,699 |
2021-10-18 | ACAD | Sale | 2,963 | 17.41 | 51,585 |
2021-10-15 | ACAD | Option Ex | 5,938 | .00 | 0 |
2021-04-29 | ACAD | Option Ex | 15,625 | .00 | 0 |
2021-04-30 | ACAD | Sale | 7,850 | 20.33 | 159,590 |
2021-02-04 | ACAD | Sale | 14,195 | 50.61 | 718,408 |
2021-01-06 | ACAD | Sale | 3,484 | 53.34 | 185,836 |
2021-01-06 | ACAD | Option Ex | 9,527 | .00 | 0 |
2020-10-16 | ACAD | Sale | 2,960 | 42.56 | 125,977 |
2020-10-15 | ACAD | Option Ex | 5,937 | .00 | 0 |
2020-05-13 | ACAD | Sale | 111,458 | 46.97 | 5,234,959 |
2020-05-14 | ACAD | Sale | 88,542 | 45.33 | 4,013,785 |
2020-05-13 | ACAD | Option Ex | 111,458 | 19.65 | 2,190,149 |
2020-05-14 | ACAD | Option Ex | 88,542 | 19.65 | 1,739,850 |
2020-04-29 | ACAD | Option Ex | 15,625 | .00 | 0 |
2020-04-30 | ACAD | Sale | 6,770 | 49.21 | 333,151 |
2019-12-05 | ACAD | Option Ex | 150,000 | 19.65 | 2,947,500 |
2019-12-05 | ACAD | Sale | 150,000 | 52.08 | 7,811,550 |
2019-10-15 | ACAD | Option Ex | 5,937 | .00 | 0 |
2019-10-15 | ACAD | Sale | 2,983 | 39.65 | 118,275 |
2019-10-10 | ACAD | Sale | 120,208 | 40.19 | 4,831,039 |
2019-10-09 | ACAD | Sale | 29,792 | 40.00 | 1,191,709 |
2019-10-10 | ACAD | Option Ex | 120,208 | 19.65 | 2,362,087 |
2019-10-09 | ACAD | Option Ex | 29,792 | 19.65 | 585,412 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Davis Stephen
(CEO of Acadia Pharmaceuticals Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.